| 7218- | GBE, | Efficacy and Safety of Ginkgo biloba in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis |
| - | Review, | Stroke, | NA |
| - | vitro+vivo, | Kidney, | HK-2 |
| 4245- | GBE, | Standardized extract of Ginkgo biloba enhances memory persistence over time |
| - | in-vivo, | AD, | NA |
| 4244- | GBE, | Effects of Six-Week Ginkgo biloba Supplementation on Aerobic Performance, Blood Pro/Antioxidant Balance, and Serum Brain-Derived Neurotrophic Factor in Physically Active Men |
| - | Human, | Nor, | NA |
| 7207- | GBE, | The molecular mechanisms of ginkgo (Ginkgo biloba) activity in signaling pathways: A comprehensive review |
| - | Review, | AD, | NA |
| 7197- | GBE, | Ginkgo biloba for cognitive impairment and dementia |
| - | Review, | AD, | NA |
| - | vitro+vivo, | HCC, | NA |
| 7195- | GBE, | Mitochondrial effects of Ginkgo biloba extract |
| - | Review, | AD, | NA |
| 7187- | GBE, | Ginkgo biloba for prevention of dementia: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 7205- | GBE, | Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders |
| - | Review, | AD, | NA |
| 7206- | GBE, | EGb 761, | Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review |
| - | Review, | AD, | NA |
| 7188- | GBE, | Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial |
| - | Trial, | AD, | NA |
| 7210- | GBE, | Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 7211- | GBE, | Ginkgo Biflavones Cause p53 Wild-Type Dependent Cell Death in a Transcription-Independent Manner of p53 |
| - | in-vitro, | CRC, | HCT116 |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 7190- | GBE, | Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis |
| - | Review, | Nor, | NA |
| 7189- | GBE, | Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx] |
| - | Trial, | NA, | NA |
| 3722- | GBE, | Alzheimer's disease: Research summaries – Do Ginkgo products help? |
| - | Review, | AD, | NA |
| 3723- | GBE, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
| - | Review, | AD, | NA |
| 1190- | GBE, | Extract of Ginkgo biloba exacerbates liver metastasis in a mouse colon cancer Xenograft model |
| - | in-vivo, | CRC, | SW-620 |
| 1189- | GBE, | New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer |
| - | Review, | NA, | NA |
| 1188- | GBE, | The potential of Ginkgo biloba in the treatment of human diseases and the relationship to Nrf2-mediated antioxidant protection |
| - | Review, | Stroke, | NA |
| 7670- | GCL2505, | Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | AD, | NA |
| 790- | Ge-132, | A Toxicological Evaluation of Germanium Sesquioxide (Organic Germanium) |
| - | vitro+vivo, | NA, | NA |
| 791- | Ge-132, | Germanium Sesquioxide Organic Germanium |
| 792- | Ge-132, | The role of germanium in diseases: exploring its important biological effects |
| 789- | Ge-132, | Complete remission of pulmonary spindle cell carcinoma after treatment with oral germanium sesquioxide |
| - | Case Report, | SCC, | NA |
| 7132- | Ge-132, | Organogermanium compound, Ge-132, forms complexes with adrenaline, ATP and other physiological cis-diol compounds |
| - | in-vitro, | Nor, | NA |
| 7117- | Ge-132, | Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblasts |
| - | in-vitro, | Nor, | NA |
| 7131- | Ge-132, | Antioxidant Activity of Ge-132, a Synthetic Organic Germanium, on Cultured Mammalian Cells |
| - | in-vitro, | Nor, | CHO K1 |
| 7130- | Ge-132, | Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer |
| - | Trial, | BC, | NA |
| 7129- | Ge-132, | Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes |
| - | in-vivo, | lymphoma, | NA |
| 7128- | Ge-132, | Pharmacokinetics of germanium after po beta-carboxyethylgermanium sesquioxide in 24 Chinese volunteers |
| - | Trial, | Nor, | NA |
| 7127- | Ge-132, | Synthesis and Evaluation of Novel Organogermanium Sesquioxides As Antitumor Agents |
| - | vitro+vivo, | Var, | NA |
| 7126- | Ge-132, | Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights |
| - | Trial, | Nor, | NA |
| 7125- | Ge-132, | A review of public and environmental consequences of organic germanium |
| - | Review, | Nor, | NA |
| 7124- | Ge-132, | Physiological Activity of Trace Element Germanium including Anticancer Properties |
| - | Review, | Var, | NA |
| 7133- | Ge-132, | Organogermanium, Ge-132, promotes the clearance of senescent red blood cells via macrophage-mediated phagocyte activation |
| - | in-vitro, | Nor, | RAW264.7 |
| 7101- | Geld, | Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs |
| - | in-vitro, | Nor, | NA |
| 7100- | Geld, | Rad, | Preferential sensitization of tumor cells to radiation by heat shock protein 90 inhibitor geldanamycin |
| - | in-vitro, | Var, | NA |
| 7099- | Geld, | Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation |
| - | in-vitro, | CRC, | DLD1 |
| 7098- | Geld, | Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy |
| - | Review, | Var, | NA |
| 7097- | Geld, | Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry |
| - | Review, | Var, | NA |
| 7096- | Geld, | A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues |
| - | Study, | Var, | NA |
| 7095- | Geld, | Mechanistic studies on Hsp90 inhibition by ansamycin derivatives |
| - | Study, | Var, | NA |
| 7108- | GEN, | Genistein: A Review on its Anti-Inflammatory Properties |
| - | Review, | Nor, | NA |
| 7109- | GEN, | Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study |
| - | Trial, | Nor, | NA |
| - | Trial, | Pca, | NA |
| 7110- | GEN, | Genistein |
| - | Review, | AD, | NA |
| 7107- | GEN, | Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients |
| - | Trial, | Pca, | NA | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid